a DNA strand in the colour blue

Join us for the upcoming Organoids Seminar hosted by Miltenyi Biotec on Friday, 17 April 2026, taking place at the Wolfson Education Centre, Lecture Theatre 1, Hammersmith Campus.

The seminar will feature introductory talks, scientific presentations, Miltenyi technical sessions, and an opportunity to network over lunch:

Schedule:
10:00 – 10:10 Inês Cebola & Vanessa Sancho-Shimizu: Introduction

10:10 – 10:30 Diana Papp (Research Manager of the Organoid Facility): Introduction to the Organoid Facility + Q&A

10:30 – 11:00 Rohan Sundramoorthi (Clinical PhD Fellow, Korcsmaros Lab):Capturing Diversity in a Dish: The Impact of Ancestry on Intestinal Organoid Phenotypes and Functional Genomics: + Q&A

11:10 – 12:00 Jak Grimes & Indrani Mukherjee (Miltenyi): High throughput 3D imaging of entire tissue with the UltraMicroscope Blaze / Beyond maintenance: your path to reproducible cell culture and differentiation with Miltenyi Biotec

12:00 – 13:00 Networking: “Have a slice of pizza with Miltenyi technical experts!”

We hope you can join us for this informative event.  Unable to attend in person? A Teams link is provided

Further Information

Functional Genomics Network

Translating genomic data into meaningful clinical insights and outcomes remains one of the greatest challenges in modern biomedical research.

At 51Թ London, expertise in computational biology, genetics, and clinical research thrives but often remains siloed. The 51Թ Excellence in Functional Genomics Network unites these strengths across faculties to foster collaboration, streamline resources, and accelerate translating genetic discoveries into better patient care.

Miltenyi Biotec

For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.

Our mission is to advance scientific understanding and medicine by providing solutions for cell and gene therapy and biomedical research. We believe in biomedical science as the strongest driver to change the way we treat cancer, autoimmune diseases, and neurodegenerative disorders.
The design of therapeutics is evolving away from chemistry-based science towards individual treatments that focus on cell-based approaches and more targeted drugs. We are driving the revolution that is reinventing medicine and advancing it to a level that will make cancer and other serious diseases history.

Getting here